Imidazole Scaffolds at the Forefront of Antifungal Drug Development: Synthetic Progress, Molecular Characterization, and In Vitro Pharmacological Insights.

Imidazole-based compounds represent one of the most extensively explored heterocyclic scaffolds in antifungal drug discovery due to their broad-spectrum activity, favorable binding affinity toward fungal targets, and well-established clinical relevance. The increasing prevalence of invasive and resistant fungal infections has intensified the demand for novel antifungal agents with improved efficacy, selectivity, and safety profiles. In this context, imidazole scaffolds continue to attract significant attention owing to their structural versatility and amenability to chemical modification. This review critically examines recent advances in the synthesis of imidazole derivatives, highlighting innovative synthetic strategies, green chemistry approaches, and structure-driven design principles employed to generate chemically diverse antifungal candidates. Emphasis is placed on molecular characterization techniques, including spectroscopic and analytical methods, which are essential for structural confirmation and purity assessment. Furthermore, the review consolidates in vitro pharmacological findings reported for imidazole derivatives against clinically relevant fungal strains, with particular focus on activity trends, potency comparisons, and emerging structure–activity relationships. Mechanistic insights into antifungal action, including interactions with fungal cell membrane sterol biosynthesis and enzyme inhibition pathways, are also discussed where available. By integrating chemical, structural, and biological perspectives, this review aims to provide a comprehensive overview of the current antifungal landscape of imidazole scaffolds. The compiled insights are expected to assist researchers in rational scaffold optimization and facilitate the development of next-generation imidazole-based antifungal agents with enhanced therapeutic potential.